OLIVOTTO, IACOPO
OLIVOTTO, IACOPO
Medicina Sperimentale e Clinica
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile
2018 Elisabetta Cerbai, Bruno Bertaccini, Michele Moraccini, Valentina Spinelli, Raffaele Coppini, Niccolò Maurizi, Giulia Biagi, Fausto Barlocco, Mattia Targetti, Gian Aristide Norelli, Giorgio Galanti, Gabriella Nesi, Iacopo Olivotto, Daniela Massi, Elisabetta Projetto, Rossella Grifoni, Benedetta Tosi, Maria Concetta Vono, Franco Lasi Pasini, Vincenzo Sorrentino, Pier Leopoldo Capecchi, Francesca Vanni, Pietro Enea Lazzerini
1473Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study
2018 Foa, A; Rapezzi, C; Olivotto, I; Cecchi, F; Coppini, R; Ferrantini, C; Stefano, P; Agostini, V; Vitale, G; Ditaranto, R; Biagini, E; Leone, O
[Assessment of left ventricular outflow tract obstruction according to the latest European guidelines on hypertrophic cardiomyopathy]
2015 Olivotto, Iacopo; Rossi, Alessandra; Stefano, Pierluigi
[Clinical relevance of genetic testing in hypertrophic cardiomyopathy].
2011 F. Girolami;S. Bardi;L. Berti;F. Cecchi;E. Servettini;B. Tomberli;F. Torricelli;I. Olivotto
[From loss to prevention: lessons to be learned from juvenile sudden death]
2022 Targetti, Mattia; Cerbai, Elisabetta; Emdin, Michele; Olivotto, Iacopo
[Molecular targets and novel pharmacological options to prevent myocardial hypertrophic remodeling]
2016 Coppini, Raffaele; Ferrantini, Cecilia; Poggesi, Corrado; Mugelli, Alessandro; Olivotto, Iacopo
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy]
2023 Argirò, Alessia; Zampieri, Mattia; Marchi, Alberto; Del Franco, Annamaria; Pàlinkàs, Eszter Dalma; Biagioni, Giulia; Chiti, Chiara; Mazzoni, Carlotta; Fornaro, Alessandra; Targetti, Mattia; Cappelli, Francesco; Olivotto, Iacopo
A computational pipeline for data augmentation towards the improvement of disease classification and risk stratification models: A case study in two clinical domains
2021 Pezoulas V.C.; Grigoriadis G.I.; Gkois G.; Tachos N.S.; Smole T.; Bosnic Z.; Piculin M.; Olivotto I.; Barlocco F.; Robnik-Sikonja M.; Jakovljevic D.G.; Goules A.; Tzioufas A.G.; Fotiadis D.I.
A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy
2021 Smole T.; Zunkovic B.; Piculin M.; Kokalj E.; Robnik-Sikonja M.; Kukar M.; Fotiadis D.I.; Pezoulas V.C.; Tachos N.S.; Barlocco F.; Mazzarotto F.; Popovic D.; Maier L.; Velicki L.; MacGowan G.A.; Olivotto I.; Filipovic N.; Jakovljevic D.G.; Bosnic Z.
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study
2022 Merlo M, Porcari A, Pagura L, Cameli M, Vergaro G, Musumeci B, Biagini E, Canepa M, Crotti L, Imazio M, Forleo C, Cappelli F, Favale S, Di Bella G, Dore F, Lombardi CM, Pavasini R, Rella V, Palmiero G, Caiazza M, Albanese M, Guaricci AI, Branzi G, Caponetti AG, Saturi G, La Malfa G, Merlo AC, Andreis A, Bruno F, Longo F, Sfriso E, Di Ienno L, De Carli G, Giacomin E, Spini V, Milidoni A, Limongelli G, Autore C, Olivotto I, Badano L, Parati G, Perlini S, Metra M, Emdin M, Rapezzi C, Sinagra G.
A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy
2020 Miron, Anastasia; Lafreniere-Roula, Myriam; Fan, Chun-Po Steve; Armstrong, Katey R; Dragulescu, Andreea; Papaz, Tanya; Manlhiot, Cedric; Kaufman, Beth; Butts, Ryan J; Gardin, Letizia; Stephenson, Elizabeth A; Howard, Taylor S; Aziz, Peter F; Balaji, Seshadri; Beauséjour Ladouceur, Virginie; Benson, Lee N; Colan, Steven D; Godown, Justin; Henderson, Heather T; Ingles, Jodie; Jeewa, Aamir; Jefferies, John L; Lal, Ashwin K; Mathew, Jacob; Jean-St-Michel, Emilie; Michels, Michelle; Nakano, Stephanie J; Olivotto, Iacopo; Parent, John J; Pereira, Alexandre C; Semsarian, Christopher; Whitehill, Robert D; Wittekind, Samuel G; Russell, Mark W; Conway, Jennifer; Richmond, Marc E; Villa, Chet; Weintraub, Robert G; Rossano, Joseph W; Kantor, Paul F; Ho, Carolyn Y; Mital, Seema
Abrupt onset of refractory heart failure associated with light-chain amyloidosis in hypertrophic cardiomyopathy
2017 Tomberli, Benedetta; Cappelli, Francesco; Perfetto, Federico; Olivotto, Iacopo
Accade-MIA. Territorio, Università e Ospedale si incontrano. Il racconto di un’esperienza
2023 Enrica Ciucci, Matteo Galletti, Chiara Fioretti, Rosanna Martin, Iacopo Olivotto, Andrea Smorti, Lucrezia Tomberli, Laura Vagnoli
Acceptability, Feasibility and Preliminary Evaluation of a Novel, Personalised, Home-Based Physical Activity Intervention for Chronic Heart Failure (Active-at-Home-HF): a Pilot Study
2019 Okwose, Nduka C; Avery, Leah; O'Brien, Nicola; Cassidy, Sophie; Charman, Sarah J; Bailey, Kristian; Velicki, Lazar; Olivotto, Iacopo; Brennan, Paul; MacGowan, Guy A; Jakovljevic, Djordje G
Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy
2020 Pioner JM, Fornaro A, Coppini R, Ceschia N, Sacconi L, Donati MA, Favilli S, Poggesi C, Olivotto I, Ferrantini C
Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy
2020 Mazzarotto F.; Olivotto I.; Walsh R.
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening
2021 Maurizi N.; Baldi M.; Castelletti S.; Lisi C.; Galli M.; Bianchi S.; Panzera F.; Fumagalli C.; Mochi N.; Parati G.; Olivotto I.; Cecchi F.
Age-related decline in contractile function of ventricular myofibrils from HCM patients carrying MYBPC3 mutations
2011 Ferrantini C.; Belus A.; Piroddi N.; Ferrara C.; Scellini B.; Tesi C.; Cecchi F.; Olivotto I.; Poggesi C.
An expert consensus document on the management of cardiovascular manifestations of Fabry disease
2020 Linhart A.; Germain D.P.; Olivotto I.; Akhtar M.M.; Anastasakis A.; Hughes D.; Namdar M.; Pieroni M.; Hagege A.; Cecchi F.; Gimeno J.R.; Limongelli G.; Elliott P.
An Investigation of the Molecular Mechanism of Double cMyBP-C Mutation in a Patient with End-Stage Hypertrophic Cardiomyopathy
2015 Gajendrarao P.; Krishnamoorthy N.; Selvaraj S.; Girolami F.; Cecchi F.; Olivotto I.; Yacoub M.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile | 2018 | Elisabetta Cerbai, Bruno Bertaccini, Michele Moraccini, Valentina Spinelli, Raffaele Coppini, Niccolò Maurizi, Giulia Biagi, Fausto Barlocco, Mattia Targetti, Gian Aristide Norelli, Giorgio Galanti, Gabriella Nesi, Iacopo Olivotto, Daniela Massi, Elisabetta Projetto, Rossella Grifoni, Benedetta Tosi, Maria Concetta Vono, Franco Lasi Pasini, Vincenzo Sorrentino, Pier Leopoldo Capecchi, Francesca Vanni, Pietro Enea Lazzerini | |
1473Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study | 2018 | Foa, A; Rapezzi, C; Olivotto, I; Cecchi, F; Coppini, R; Ferrantini, C; Stefano, P; Agostini, V; Vitale, G; Ditaranto, R; Biagini, E; Leone, O | |
[Assessment of left ventricular outflow tract obstruction according to the latest European guidelines on hypertrophic cardiomyopathy] | 2015 | Olivotto, Iacopo; Rossi, Alessandra; Stefano, Pierluigi | |
[Clinical relevance of genetic testing in hypertrophic cardiomyopathy]. | 2011 | F. Girolami;S. Bardi;L. Berti;F. Cecchi;E. Servettini;B. Tomberli;F. Torricelli;I. Olivotto | |
[From loss to prevention: lessons to be learned from juvenile sudden death] | 2022 | Targetti, Mattia; Cerbai, Elisabetta; Emdin, Michele; Olivotto, Iacopo | |
[Molecular targets and novel pharmacological options to prevent myocardial hypertrophic remodeling] | 2016 | Coppini, Raffaele; Ferrantini, Cecilia; Poggesi, Corrado; Mugelli, Alessandro; Olivotto, Iacopo | |
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy] | 2023 | Argirò, Alessia; Zampieri, Mattia; Marchi, Alberto; Del Franco, Annamaria; Pàlinkàs, Eszter Dalma; Biagioni, Giulia; Chiti, Chiara; Mazzoni, Carlotta; Fornaro, Alessandra; Targetti, Mattia; Cappelli, Francesco; Olivotto, Iacopo | |
A computational pipeline for data augmentation towards the improvement of disease classification and risk stratification models: A case study in two clinical domains | 2021 | Pezoulas V.C.; Grigoriadis G.I.; Gkois G.; Tachos N.S.; Smole T.; Bosnic Z.; Piculin M.; Olivotto I.; Barlocco F.; Robnik-Sikonja M.; Jakovljevic D.G.; Goules A.; Tzioufas A.G.; Fotiadis D.I. | |
A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy | 2021 | Smole T.; Zunkovic B.; Piculin M.; Kokalj E.; Robnik-Sikonja M.; Kukar M.; Fotiadis D.I.; Pezoulas V.C.; Tachos N.S.; Barlocco F.; Mazzarotto F.; Popovic D.; Maier L.; Velicki L.; MacGowan G.A.; Olivotto I.; Filipovic N.; Jakovljevic D.G.; Bosnic Z. | |
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study | 2022 | Merlo M, Porcari A, Pagura L, Cameli M, Vergaro G, Musumeci B, Biagini E, Canepa M, Crotti L, Imazio M, Forleo C, Cappelli F, Favale S, Di Bella G, Dore F, Lombardi CM, Pavasini R, Rella V, Palmiero G, Caiazza M, Albanese M, Guaricci AI, Branzi G, Caponetti AG, Saturi G, La Malfa G, Merlo AC, Andreis A, Bruno F, Longo F, Sfriso E, Di Ienno L, De Carli G, Giacomin E, Spini V, Milidoni A, Limongelli G, Autore C, Olivotto I, Badano L, Parati G, Perlini S, Metra M, Emdin M, Rapezzi C, Sinagra G. | |
A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy | 2020 | Miron, Anastasia; Lafreniere-Roula, Myriam; Fan, Chun-Po Steve; Armstrong, Katey R; Dragulescu, Andreea; Papaz, Tanya; Manlhiot, Cedric; Kaufman, Beth; Butts, Ryan J; Gardin, Letizia; Stephenson, Elizabeth A; Howard, Taylor S; Aziz, Peter F; Balaji, Seshadri; Beauséjour Ladouceur, Virginie; Benson, Lee N; Colan, Steven D; Godown, Justin; Henderson, Heather T; Ingles, Jodie; Jeewa, Aamir; Jefferies, John L; Lal, Ashwin K; Mathew, Jacob; Jean-St-Michel, Emilie; Michels, Michelle; Nakano, Stephanie J; Olivotto, Iacopo; Parent, John J; Pereira, Alexandre C; Semsarian, Christopher; Whitehill, Robert D; Wittekind, Samuel G; Russell, Mark W; Conway, Jennifer; Richmond, Marc E; Villa, Chet; Weintraub, Robert G; Rossano, Joseph W; Kantor, Paul F; Ho, Carolyn Y; Mital, Seema | |
Abrupt onset of refractory heart failure associated with light-chain amyloidosis in hypertrophic cardiomyopathy | 2017 | Tomberli, Benedetta; Cappelli, Francesco; Perfetto, Federico; Olivotto, Iacopo | |
Accade-MIA. Territorio, Università e Ospedale si incontrano. Il racconto di un’esperienza | 2023 | Enrica Ciucci, Matteo Galletti, Chiara Fioretti, Rosanna Martin, Iacopo Olivotto, Andrea Smorti, Lucrezia Tomberli, Laura Vagnoli | |
Acceptability, Feasibility and Preliminary Evaluation of a Novel, Personalised, Home-Based Physical Activity Intervention for Chronic Heart Failure (Active-at-Home-HF): a Pilot Study | 2019 | Okwose, Nduka C; Avery, Leah; O'Brien, Nicola; Cassidy, Sophie; Charman, Sarah J; Bailey, Kristian; Velicki, Lazar; Olivotto, Iacopo; Brennan, Paul; MacGowan, Guy A; Jakovljevic, Djordje G | |
Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy | 2020 | Pioner JM, Fornaro A, Coppini R, Ceschia N, Sacconi L, Donati MA, Favilli S, Poggesi C, Olivotto I, Ferrantini C | |
Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy | 2020 | Mazzarotto F.; Olivotto I.; Walsh R. | |
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening | 2021 | Maurizi N.; Baldi M.; Castelletti S.; Lisi C.; Galli M.; Bianchi S.; Panzera F.; Fumagalli C.; Mochi N.; Parati G.; Olivotto I.; Cecchi F. | |
Age-related decline in contractile function of ventricular myofibrils from HCM patients carrying MYBPC3 mutations | 2011 | Ferrantini C.; Belus A.; Piroddi N.; Ferrara C.; Scellini B.; Tesi C.; Cecchi F.; Olivotto I.; Poggesi C. | |
An expert consensus document on the management of cardiovascular manifestations of Fabry disease | 2020 | Linhart A.; Germain D.P.; Olivotto I.; Akhtar M.M.; Anastasakis A.; Hughes D.; Namdar M.; Pieroni M.; Hagege A.; Cecchi F.; Gimeno J.R.; Limongelli G.; Elliott P. | |
An Investigation of the Molecular Mechanism of Double cMyBP-C Mutation in a Patient with End-Stage Hypertrophic Cardiomyopathy | 2015 | Gajendrarao P.; Krishnamoorthy N.; Selvaraj S.; Girolami F.; Cecchi F.; Olivotto I.; Yacoub M. |